McKew John C.
Chief Scientific Officer at LUMOS PHARMA, INC.
- Sold, on record
- $106k
- Dollars the filings state
- Form 4 sales
- 10
- Latest Aug 6, 2024
- Form 144 notices
- 2
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- LUMOS PHARMA, INC.Chief Scientific Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale LUMOS PHARMA, INC.Plan not statedFeb 2, 2023 2023
Sold 439 shares at $3.53 ($2k)
McKew John C., Chief Scientific Officer
Sold 1.6% of holdings ($95k position)26,457 shares left0.2x usual sizeFiling
- 2 Form 4 sale LUMOS PHARMA, INC.RoutineApr 4, 2023 +61 days
Sold 2,214 shares at $3.27 ($7k)
McKew John C., Chief Scientific Officer
10b5-1 planSold 8.7% of holdings ($83k position)23,207 shares left1x usual sizeFiling
- 3 Form 144 notice LUMOS PHARMA, INC.NoticeAug 2, 2023 +120 days
Filed to sell 3,407 shares ($11k)
McKew John C., Officer
10b5-1 plan1.5x usual sizeFiling
- 4 Form 4 sale LUMOS PHARMA, INC.RoutineAug 2, 2023 same day
Sold 3,407 shares at $3.21 ($11k)
McKew John C., Chief Scientific Officer
10b5-1 planSold 15.4% of holdings ($71k position)18,707 shares left1.5x usual sizeFollows a Form 144Filing
- 5 Form 144 notice LUMOS PHARMA, INC.NoticeFeb 6, 2024 +188 days
Filed to sell 438 shares ($1k)
McKew John C., Officer
10b5-1 plan0.2x usual sizeFiling
- 6 Form 4 sale LUMOS PHARMA, INC.RoutineFeb 6, 2024 same day
Sold 438 shares at $3.03 ($1k)
McKew John C., Chief Scientific Officer
10b5-1 planSold 2.3% of holdings ($57k position)18,403 shares left0.2x usual sizeFollows a Form 144Filing
- 7 Form 4 sale LUMOS PHARMA, INC.RoutineApr 3, 2024 +57 days
Sold 2,214 shares at $2.78 ($6k)
McKew John C., Chief Scientific Officer
10b5-1 planSold 11.4% of holdings ($54k position)17,153 shares left1x usual sizeFiling
- 8 Form 4 sale LUMOS PHARMA, INC.RoutineAug 6, 2024 +125 days
Sold 3,407 shares at $1.89 ($6k)
McKew John C., Chief Scientific Officer
10b5-1 planSold 21.2% of holdings ($30k position)12,653 shares left1.5x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (12)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 6, 2024 | Aug 6, 2024 | LUMOS PHARMA, INC. | Chief Scientific Officer | Form 4 sale | 3,407 | $6k | 21.2% | Routine | SEC |
| Apr 3, 2024 | Apr 3, 2024 | LUMOS PHARMA, INC. | Chief Scientific Officer | Form 4 sale | 2,214 | $6k | 11.4% | Routine | SEC |
| Feb 6, 2024 | Feb 7, 2024 | LUMOS PHARMA, INC. | Chief Scientific Officer | Form 4 sale | 438 | $1k | 2.3% | Routine | SEC |
| Feb 6, 2024 | Feb 6, 2024 | LUMOS PHARMA, INC. | Officer | Form 144 notice | 438 | $1k | Notice | SEC | |
| Aug 2, 2023 | Aug 3, 2023 | LUMOS PHARMA, INC. | Chief Scientific Officer | Form 4 sale | 3,407 | $11k | 15.4% | Routine | SEC |
| Aug 2, 2023 | Aug 2, 2023 | LUMOS PHARMA, INC. | Officer | Form 144 notice | 3,407 | $11k | Notice | SEC | |
| Apr 4, 2023 | Apr 4, 2023 | LUMOS PHARMA, INC. | Chief Scientific Officer | Form 4 sale | 2,214 | $7k | 8.7% | Routine | SEC |
| Feb 2, 2023 | Feb 3, 2023 | LUMOS PHARMA, INC. | Chief Scientific Officer | Form 4 sale | 439 | $2k | 1.6% | Plan not stated | SEC |
| Aug 2, 2022 | Aug 3, 2022 | LUMOS PHARMA, INC. | Chief Scientific Officer | Form 4 sale | 3,407 | $28k | 12.2% | Plan not stated | SEC |
| Jun 6, 2022 | Jun 7, 2022 | LUMOS PHARMA, INC. | Chief Scientific Officer | Form 4 sale | 169 | $1k | 0.6% | Plan not stated | SEC |
| Apr 5, 2022 | Apr 5, 2022 | LUMOS PHARMA, INC. | Chief Scientific Officer | Form 4 sale | 2,214 | $18k | 7.0% | Plan not stated | SEC |
| Sep 8, 2021 | Sep 10, 2021 | LUMOS PHARMA, INC. | Chief Scientific Officer | Form 4 sale | 2,214 | $25k | 6.7% | Plan not stated | SEC |